Abdullah, Z. ., Cui, Y. ., Platt, R. W., Renoux, C. ., Azoulay, L. ., Xia, C. ., & H. Y. Yu, O. . (2025). Association between use of sodium-glucose co-transporter-2 inhibitor and the risk of incident dementia: a population-based cohort study. BMJ Open Diabetes Res Care, 13. http://doi.org/10.1136/bmjdrc-2024-004541
Y. Cui
First name
Y.
Last name
Cui
Wang, W. ., Cui, Y. ., H. Y. Yu, O. ., Suissa, S. ., & Douros, A. . (2024). The Prevalent New-User Design to Study Drug-Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia. Pharmacoepidemiol Drug Saf, 33, e70014. http://doi.org/10.1002/pds.70014
Dimakos, J. ., Cui, Y. ., Platt, R. W., Renoux, C. ., Filion, K. B., & Douros, A. . (2024). Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.15627
Dimakos, J. ., Cui, Y. ., Platt, R. W., Renoux, C. ., Filion, K. B., & Douros, A. . (2023). Pharmacologic heterogeneity and risk of severe hypoglycemia with concomitant use of sulfonylureas and DPP-4 inhibitors: population-based cohort study. Clin Pharmacol Ther. http://doi.org/10.1002/cpt.2975
Dimakos, J. ., Cui, Y. ., Platt, R. W., Renoux, C. ., Filion, K. B., & Douros, A. . (2022). Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study. Diabetes Care. http://doi.org/10.2337/dc22-1584
Douros, A. ., Cui, Y. ., Platt, R. W., Filion, K. B., Sebastiani, G. ., & Renoux, C. . (2021). Utilization and long-term persistence of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15046